Jingrong Lin

Jingrong Lin

Auto-generated profile, based on publicly available information

Jingrong Lin


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2023 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
XLXiran Lin
Xiran Lin
XMXianmin Meng
Xianmin Meng
JLJingrong Lin
Jingrong Lin

22 August 2017 in International Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
YYYi Yang
Yi Yang
JLJingrong Lin
Jingrong Lin
SFShifeng Fang
Shifeng Fang
SHShixin Han
Shixin Han
ZSZhiqi Song
Zhiqi Song

28 July 2018 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
DZDongmei Zhang
Dongmei Zhang
JLJingrong Lin
Jingrong Lin
YCYulin Chao
Yulin Chao
ZLZhang Lu
Zhang Lu
LJLei Jin
Lei Jin
CHChuanchun Han
Chuanchun Han
Background: Adaptation to ER stress has been indicated to play an important role in resistance to therapy in human melanoma. However, the relationship between adaptation to ER stress and cell metastasis in human melanoma remains unclear. Methods: The relationship of adaptation to ER stress and cell metastasis was investigated using transwell and mouse metastasis assays. The potential molecular mechanism of KLF4 in regulating the adaptation to ER stress and cell metastasis was investigated using RNA sequencing analysis, q-RT-PCR and western blot assays. The transcriptional regulation of nucleobindin 2 (NUCB2) by KLF4 was identified using bioinformatic analysis, luciferase assay, and chromatin immunoprecipitation (ChIP). The clinical significance of KLF4 and NUCB2 was based on human tissue microarray (TMA) analysis. Results: Here, we demonstrated that KLF4 was induced by ER stress in melanoma cells, and increased KLF4 inhibited cell apoptosis and promoted cell metastasis. Further mechanistic studies revealed that KLF4 directly bound to the promoter of NUCB2, facilitating its transcription. Additionally, an increase in KLF4 promoted melanoma ER stress resistance, tumour growth and cell metastasis by regulating NCUB2 expression in vitro and in vivo. Elevated KLF4 was found in human melanoma tissues, which was associated with NUCB2 expression. Conclusion: Our data revealed that the promotion of ER stress resistance via the KLF4-NUCB2 axis is essential for melanoma cell metastasis, and KLF4 may be a promising specific target for melanoma therapy.

1 December 2020 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
XLXiran Lin
Xiran Lin
XMXianmin Meng
Xianmin Meng
ZSZhiqi Song
Zhiqi Song
JLJingrong Lin
Jingrong Lin

4 September 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HGHewen Guan
Hewen Guan
XCXu Chen
Xu Chen
JLJifeng Liu
Jifeng Liu
JSJiaao Sun
Jiaao Sun
HGHui Guo
Hui Guo
QYQihang Yuan
Qihang Yuan
Melanoma is a malignant tumor of melanocytes and is often considered immunogenic cancer. Toll-like receptor-related genes are expressed differently in most types of cancer, depending on the immune microenvironment inside cancer, and the key function of Toll-like receptors (TLRs) for melanoma has not been fully elucidated. Based on multi-omics data from TCGA and GEO databases, we first performed pan-cancer analysis on TLR, including CNV, SNV, and mRNA changes in TLR-related genes in multiple human cancers, as well as patient prognosis characterization. Then, we divided melanoma patients into three subgroups (clusters 1, 2, and 3) according to the expression of the TLR pathway, and explored the correlation between TLR pathway and melanoma prognosis, immune infiltration, metabolic reprogramming, and oncogene expression characteristics. Finally, through univariate Cox regression analysis and LASSO algorithm, we selected six TLR-related genes to construct a survival prognostic model, divided melanoma patients into the training set, internal validation set 1, internal validation set 2, and external validation set for multiple validations, and discussed the correlation between model genes and clinical features of melanoma patients. In conclusion, we constructed a prognostic survival model based on TLR-related genes that precisely and independently demonstrated the potential to assess the prognosis and immune traits of melanoma patients, which is critical for patients’ survival.

2 May 2021 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
JLJia Liu
Jia Liu
FCFeng Cao
Feng Cao
XLXiaojie Li
Xiaojie Li
LZLi Zhang
Li Zhang
ZLZhengrong Liu
Zhengrong Liu
CHChuanchun Han
Chuanchun Han
ITIH5, a member of the inter-α-trypsin inhibitory (ITI) gene family, acts as a putative tumour-suppressor gene in many cancers. However, its role and the regulatory mechanism in melanoma are still unclear. Here, we found that the expression of ITIH5 was decreased in melanoma tissues compared with normal skin tissues. Decreased expression of ITIH5 was correlated with clinicopathological features and predicted poor prognosis in patients with melanoma. Forced expression of ITIH5 significantly inhibited melanoma cell proliferation and metastasis in vitro and ex vivo while knockdown of ITIH5 expression enhanced the malignant behaviour of melanoma cells. In further mechanistic studies, we showed that p53 can directly bind to the promoter of ITIH5 and thus promotes transcription of ITIH5 in melanoma cells. Additionally, we found that ITIH5 interacted with Krüppel-like factor 4 (KLF4) and inhibited its transcriptional activity. Collectively, our data not only identified a tumour-suppressive role of ITIH5 in melanoma but also revealed that upregulation of ITIH5 by p53 suppressed melanoma cell growth and migration likely by downmodulating the transcriptional activity of KLF4.